| Title |
Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer
|
|---|---|
| Published in |
Breast Cancer Research, November 2019
|
| DOI | 10.1186/s13058-019-1202-4 |
| Pubmed ID | |
| Authors |
Jin Sun Lee, Susan E. Yost, Suzette Blanchard, Daniel Schmolze, Hongwei Holly Yin, Raju Pillai, Kim Robinson, Aileen Tang, Norma Martinez, Jana Portnow, Wei Wen, John H. Yim, Heather Ann Brauer, Yuqi Ren, Thehang Luu, Joanne Mortimer, Yuan Yuan |
Mendeley readers
The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 79 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 11 | 14% |
| Student > Ph. D. Student | 10 | 13% |
| Student > Master | 8 | 10% |
| Other | 4 | 5% |
| Student > Doctoral Student | 4 | 5% |
| Other | 12 | 15% |
| Unknown | 30 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 12 | 15% |
| Medicine and Dentistry | 10 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 13% |
| Nursing and Health Professions | 5 | 6% |
| Agricultural and Biological Sciences | 3 | 4% |
| Other | 5 | 6% |
| Unknown | 34 | 43% |